In 8250 event-free patients with multivessel coronary disease 12 months after drug-eluting stenting, 12 more months of clopidogrel plus aspirin vs aspirin alone cut CV death, MI or stroke (5.8% vs 6.8%; HR 0.82) with no rise in BARC ≥2 bleeding (1.4% vs 1.5%).
RCTn = 8,250
Tian et al. Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease